Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
American Journal of Clinical Pathology
|
December 25, 2019
Comparison Between Integrated Genomic DNA/RNA Profiling and Fluorescence In Situ Hybridization in the Detection of MYC, BCL-2, and BCL-6 Gene Rearrangements in Large B-Cell Lymphomas
Daniel P Cassidy, Jennifer R Chapman, Rafael Lopez, et al.
JCO Precision Oncology
|
September 14, 2020
Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens
Margaret A Hay, Eric A Severson, Vincent A Miller, et al.
Oncology and Therapy
|
November 14, 2023
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
Heidi Ko, Rebecca A Previs, Kyle C Strickland, et al.
Cancer Medicine
|
June 24, 2022
Genomic landscape of non-small-cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency
Prashanth Ashok Kumar, Stephen L Graziano, Natalie Danziger, et al.
Frontiers in Oncology
|
December 12, 2024
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1
Zachary D Wallen, Mary K Nesline, Marni Tierno, et al.
Oncotarget
|
July 2, 2019
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma
Celina Ang, Samuel J Klempner, Siraj M Ali, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2007
Novel structural determinants on SIRP alpha that mediate binding to CD47
Winston Y Lee, Dominique A Weber, Oskar Laur, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2008
Annexin A1 regulates intestinal mucosal injury, inflammation, and repair
Brian A Babbin, Mike G Laukoetter, Porfirio Nava, et al.
Frontiers in Oncology
|
July 10, 2023
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
Paulina Czajka-Francuz, Maria J Prendes, Arun Mankan, et al.
Frontiers in Oncology
|
March 18, 2025
From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates
Heidi C Ko, Kyle C Strickland, Dana Jaggessarsingh, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
American Journal of Clinical Pathology
|
December 25, 2019
Comparison Between Integrated Genomic DNA/RNA Profiling and Fluorescence In Situ Hybridization in the Detection of MYC, BCL-2, and BCL-6 Gene Rearrangements in Large B-Cell Lymphomas
Daniel P Cassidy, Jennifer R Chapman, Rafael Lopez, et al.
JCO Precision Oncology
|
September 14, 2020
Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens
Margaret A Hay, Eric A Severson, Vincent A Miller, et al.
Oncology and Therapy
|
November 14, 2023
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
Heidi Ko, Rebecca A Previs, Kyle C Strickland, et al.
Cancer Medicine
|
June 24, 2022
Genomic landscape of non-small-cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiency
Prashanth Ashok Kumar, Stephen L Graziano, Natalie Danziger, et al.
Frontiers in Oncology
|
December 12, 2024
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1
Zachary D Wallen, Mary K Nesline, Marni Tierno, et al.
Oncotarget
|
July 2, 2019
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma
Celina Ang, Samuel J Klempner, Siraj M Ali, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2007
Novel structural determinants on SIRP alpha that mediate binding to CD47
Winston Y Lee, Dominique A Weber, Oskar Laur, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2008
Annexin A1 regulates intestinal mucosal injury, inflammation, and repair
Brian A Babbin, Mike G Laukoetter, Porfirio Nava, et al.
Frontiers in Oncology
|
July 10, 2023
Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy
Paulina Czajka-Francuz, Maria J Prendes, Arun Mankan, et al.
Frontiers in Oncology
|
March 18, 2025
From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates
Heidi C Ko, Kyle C Strickland, Dana Jaggessarsingh, et al.
Page
of 5